FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ participó en un H2020: The increasing life expectancy of the population and the development of effective therapies result in a growing population of aged cancer survivors, which frequently have comorbidities for developing...
2021-06-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ participó en un H2020: RITA-MI 2 will assess the impact of a novel therapeutic strategy targeting patients’ immune response on the recovery of heart function after myocardial infarction (MI) in a phase 2 clinical trial.Card...
2021-06-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ tramitó un AEI: LAS TASAS DE SUICIDIO ESTAN AUMENTANDO EN EL MUNDO A PESAR DE LOS ESFUERZOS DE PREVENCION. EL SEGUIMIENTO EN TIEMPO REAL MEDIANTE SMARTPHONES PUEDE AYUDARNOS A PREVENIR EL SUICIDIO. EN LOS ULTIMOS AÑO...
2021-01-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ tramitó un AEI: LA PREVALENCIA DE LAS ENFERMEDADES CRONICAS METABOLICAS ESTA EN CONTINUO AUMENTO EN LOS PAISES INDUSTRIALIZADOS. LAS ENFERMEDADES CARDIOVASCULARES, RENALES Y HEPATICAS JUNTO CON LA DIABETES Y OTRAS CO...
2021-01-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ tramitó un AEI:
2021-01-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ tramitó un AEI:
2021-01-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ participó en un H2020: UnCoVer is a functional network of research institutions collecting data derived from the provision of care to COVID-19 patients by health systems across Europe and internationally. These real-world d...
2020-11-15 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ tramitó un H2020: Lymphoid leukemias and lymphomas represent frequent areas of the tumour pathology. Recent Integrative clinical and molecular studies allows to identify concrete disorders where a precise recognition l...
2020-09-28 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ participó en un H2020: Faecal incontinence (FI) is a common condition affecting ~67 million people in Europe, seriously impairing living and productivity of affected individuals and their families. Women with FI arising fro...
2020-09-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ participó en un H2020: System omics to unravel the gut-kidney axis in Chronic Kidney Disease:There is a great need for multi-disciplinary and methodologically well trained scientists in order to unravel complex diseases. Ch...
2020-02-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ tramitó un AEI:
2020-01-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ participó en un H2020: Sudden cardiac death (SCD) is a major public health problem accounting for ~20% of all deaths in Europe with an estimated yearly incidence of ~350-700,000, often in patients with previous myocardial i...
2020-01-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ participó en un FP7: Cardiac toxicity is one of the most frequent serious side effects of cancer therapy, affecting up to 30% of treated patients. Cancer treatment-induced cardiotoxicity (CTiCT) can result in severe heart...
2019-09-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ tramitó un H2020: Rare cancersRare cancers are associated with poor survival, accounting for 22% of new cancer diagnoses in Europe, and 30% of cancer deaths. Sarcomas are a heterogeneous group of life-threatening rare...
2019-01-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ tramitó un AEI:
2019-01-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ tramitó un AEI: EL REMODELADO VASCULAR PATOLOGICO, INCLUYENDO LAS ENFERMEDADES VASCULARES OBSTRUCTIVAS (ATEROSCLEROSIS) Y DILATANTES (ANEURISMA AORTICO ABDOMINAL, AAA), SON UNA DE LAS PRINCIPALES CAUSAS DE MUERTE Y D...
2019-01-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ tramitó un AEI: LAS ENFERMEDADES CARDIOVASCULARES, RENALES Y METABOLICAS CON LA PRINCIPAL CAUSA DE MUERTE EN EL MUNDO, CON 20 MILLONES DE MUERTES CADA AÑO, ASI, LOS PACIENTES CON DIABETES TIPO 2 PRESENTAN 2 VECES MAS...
2018-01-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ tramitó un AEI: THE EPILEPSIES CONSTITUTE A GROUP OF COMMON (WORLDWIDE PREVALENCE = 1%) AND CHRONIC DISORDERS THAT SEVERELY AFFECT THE QUALITY OF LIFE OF PATIENTS, ESPECIALLY OF THOSE WHO ARE DRUG-RESISTANT, TWO MAIN...
2018-01-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ participó en un H2020: Successfully combatting a complex disease requires multi-disciplinary and methodically well-trained scientists. CaReSyAn strives to accomplish exactly this: we will train scientists to successfully in...
2018-01-01 | Financiado

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ participó en un H2020: Usher syndrome (USH) is the most common combination of deafness and blindness due to retinitis pigmentosa. USHIB caused by mutations in the large MYO7A gene, is among the most severe and frequent fo...
2018-01-01 | Financiado